MDRX: Allscripts, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : MDRX: Allscripts, Inc.

MDRX 4.500

0.0%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: JakeStraw	6/28/2011 2:32:17 PM
	of 716

We have a "buy" rating and a $25 target, which represents about 25% upside from current levels. I'll give you three main reasons why we like Allscripts. One, we think the market is underappreciating Allscripts' market-leading, hospital-to-physician product offering. And that's really only matched by a few other players, one of which is private. So that gives them high-quality exposure to the EHR adoption story on both the hospital and physician side. Number two, Allscripts has an experienced management team which has successfully generated above-market shareholder returns after the Misys deal a few years ago. And so far they appear to be following a similar playbook post the Eclipsys deal, which closed near the end of 2010. Number three, Allscripts trades at a discount valuations to group at 19 times 2012 EPS versus the group at 24 times, and we think there may be possible upside to Allscripts' numbers in out years. In fact, we actually just had the Allscripts management team on the road, and we came away with further support to our "buy" thesis. finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next